Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer |
Docetaxel, Paclitaxel, Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer |
Duloxetine, Duloxetine Hydrochloride, Oxaliplatin, Placebo, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer |
Interview, Questionnaire Administration |
Active, not recruiting |
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment |
Assessment of Therapy Complications, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors |
Biospecimen Collection, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Fat Emulsion in Preventing Hypersensitivity Reactions in Patients With Cancer Receiving Carboplatin or Oxaliplatin |
Fat Emulsion, Placebo |
Active, not recruiting |
Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment |
Quality-of-Life Assessment, Questionnaire Administration |
Active, not recruiting |
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) |
Monosialotetrahexosylganglioside, Paclitaxel, Placebo Administration, Quality-of-life assessment, Questionnaire Administration |
Recruiting |
Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors |
Biospecimen Collection, Fisetin, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration |
Recruiting |
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer |
Androgen deprivation therapy, Flibanserin 100 MG, Placebo |
Recruiting |